Novartis enters fight against HHS for denying its 340B rebate modelnews2025-01-16T16:20:31+00:00January 16th, 2025|Endpoints News|
Vertex’s fertility support bid is ‘self-serving,’ HHS saysnews2025-01-15T20:21:52+00:00January 15th, 2025|Endpoints News|
FTC goes after pharma middlemen’s price hikes on ‘specialty’ drugsnews2025-01-14T16:15:58+00:00January 14th, 2025|Endpoints News|
Federal Circuit upholds Novartis patent for heart drug Entrestonews2025-01-13T19:09:46+00:00January 13th, 2025|Endpoints News|
Lawmakers ask administration to tighten China trial rulesnews2025-01-10T20:03:11+00:00January 10th, 2025|Endpoints News|
Catalyst staves off Firdapse competition from Teva for a decadenews2025-01-09T19:32:09+00:00January 9th, 2025|Endpoints News|
Aetna takes Takeda to court over ‘anticompetitive scheme’ with generic drugsnews2025-01-07T20:01:45+00:00January 7th, 2025|Endpoints News|
Florida car dealer joins insulin pricing fight against Eli Lilly, Sanofinews2025-01-03T19:28:08+00:00January 3rd, 2025|Endpoints News|
Eli Lilly seeks to join lawsuit over end of tirzepatide shortagenews2025-01-03T18:08:24+00:00January 3rd, 2025|Endpoints News|
BioNTech settles with NIH, UPenn in Covid vaccine disputes and will pay royaltiesnews2024-12-27T15:23:42+00:00December 27th, 2024|Endpoints News|
